Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced new draft guidance aimed at reducing the cost and complexity of developing biosimilar medicines, a move the agency says could …
FDA Moves to Cut Costs for Biosimilar Drug Development Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has released a series of announcements covering a wide range of initiatives and regulatory updates, reflecting the agency’s ongoing commitment …
FDA Unveils Key Updates on Rare Disease Advances, Food Safety, and Medical Innovations Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently approved Merilog (insulin-aspart-szjj) as the first rapid-acting insulin biosimilar to Novolog (insulin aspart). This new treatment option, aimed at …
FDA Approves Groundbreaking Rapid-Acting Insulin Biosimilar Merilog, Offering New Hope for Millions Battling Diabetes Read More
BERWYN, PA — AscellaHealth has unveiled its latest edition of the Specialty & Rare Pipeline Digest™, a vital digital resource that tracks developments in specialty and rare disease medications, including …
AscellaHealth Highlights Market Trends with Specialty & Rare Pipeline Digest Read More